<SEC-DOCUMENT>0000784199-17-000088.txt : 20171002
<SEC-HEADER>0000784199-17-000088.hdr.sgml : 20171002
<ACCEPTANCE-DATETIME>20171002083446
ACCESSION NUMBER:		0000784199-17-000088
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		2
CONFORMED PERIOD OF REPORT:	20171002
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20171002
DATE AS OF CHANGE:		20171002

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CRYOLIFE INC
		CENTRAL INDEX KEY:			0000784199
		STANDARD INDUSTRIAL CLASSIFICATION:	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
		IRS NUMBER:				592417093
		STATE OF INCORPORATION:			FL
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-13165
		FILM NUMBER:		171113130

	BUSINESS ADDRESS:	
		STREET 1:		1655 ROBERTS BOULEVARD N W
		CITY:			KENNESAW
		STATE:			GA
		ZIP:			30144
		BUSINESS PHONE:		7704193355

	MAIL ADDRESS:	
		STREET 1:		1655 ROBERTS BOULEVARD N W
		CITY:			KENNESAW
		STATE:			GA
		ZIP:			30144
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>c199-20171002x8k.htm
<DESCRIPTION>8-K
<TEXT>
<!--HTML document created with Certent Disclosure Management 6.10.0.3-->
<!--Created on: 10/2/2017 8:31:28 AM-->
<html>
	<head>
		<title>
			20171002 8K Burbank
		</title>
	</head>
	<body><div style="margin-left:72pt;margin-right:72pt;">
		<div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;margin-left:0pt;">
			<tr>
				<td valign="top" style="width:478.80pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt 6.5pt">
					<p style="margin:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 1pt">
						<a name="_GoBack"></a><font style="display: inline;font-size:1pt;">&#xFEFF;</font><a name="_DV_M0"></a></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:478.80pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2.25pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt 6.5pt">
					<p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;font-weight:bold;">&#xFEFF;</font></p>
				</td>
			</tr>
		</table></div>
		<p style="margin:0pt;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 14pt">
			<font style="display: inline;font-weight:bold;font-size:14pt;">UNITED STATES</font>
		</p>
		<p style="margin:0pt;line-height:13pt;text-align:center;font-family:Times New Roman;font-size: 14pt">
			<a name="_DV_M1"></a><font style="display: inline;font-weight:bold;font-size:14pt;">SECURITIES AND EXCHANGE COMMISSION</font><br /><font style="display: inline;font-weight:bold;"></font><font style="display: inline;font-weight:bold;font-family:Times New Roman;font-weight:bold;font-size:13pt;">Washington, D</font><font style="display: inline;font-weight:bold;font-family:Times New Roman;font-weight:bold;font-size:13pt;">.</font><font style="display: inline;font-weight:bold;font-family:Times New Roman;font-weight:bold;font-size:13pt;">C</font><font style="display: inline;font-weight:bold;font-family:Times New Roman;font-weight:bold;font-size:13pt;">. &nbsp;</font><font style="display: inline;font-weight:bold;font-family:Times New Roman;font-weight:bold;font-size:13pt;">20549</font><br /><font style="display: inline;font-weight:bold;">&nbsp;</font>
		</p>
		<div style="width:100%"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;margin-left:0pt;">
			<tr>
				<td valign="top" style="width:126.00pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt 6.5pt;">
					<p style="margin:12pt 0pt;line-height:13pt;text-align:center;font-family:Times New Roman;font-size: 14pt">
						<font style="display: inline;font-weight:bold;font-size:14pt;">FORM 8-K</font></p>
				</td>
			</tr>
		</table></div>
		<p style="margin:0pt;line-height:13pt;text-align:center;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;font-weight:bold;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;line-height:13pt;text-align:center;font-family:Times New Roman;font-size: 12pt">
			<a name="_DV_M2"></a><font style="display: inline;font-weight:bold;">CURRENT REPORT</font><br /><font style="display: inline;font-weight:bold;">PURSUANT TO SECTION 13 OR 15(d) OF THE</font>
		</p>
		<p style="margin:0pt;line-height:13pt;text-align:center;font-family:Times New Roman;font-size: 12pt">
			<a name="_DV_M3"></a><font style="display: inline;font-weight:bold;">SECURITIES EXCHANGE ACT OF 1934</font><br /><font style="display: inline;font-weight:bold;"></font>
		</p>
		<p style="margin:0pt;line-height:13pt;text-align:center;font-family:Times New Roman;font-size: 10pt">
			<a name="_DV_M4"></a><font style="display: inline;font-weight:bold;font-size:10pt;">Date of Report (Date of earli</font><font style="display: inline;font-weight:bold;font-size:10pt;">e</font><font style="display: inline;font-weight:bold;font-size:10pt;">st event reported):&nbsp; </font><font style="display: inline;font-weight:bold;font-size:10pt;">October </font><font style="display: inline;font-weight:bold;font-size:10pt;">2</font><font style="display: inline;font-weight:bold;font-size:10pt;">, 201</font><font style="display: inline;font-weight:bold;font-size:10pt;">7</font><br /><font style="display: inline;font-weight:bold;font-size:10pt;"></font>
		</p>
		<p style="margin:0pt;line-height:13pt;text-align:center;font-family:Times New Roman;font-size: 12pt">
			<a name="_DV_M5"></a><font style="display: inline;font-weight:bold;">_______________________</font><br /><font style="display: inline;font-weight:bold;"></font>
		</p>
		<p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 18pt">
			<a name="_DV_M6"></a><font style="display: inline;font-weight:bold;font-size:18pt;">CRYOLIFE, INC.</font>
		</p>
		<p style="margin:0pt;line-height:13pt;text-align:center;font-family:Times New Roman;font-size: 10pt">
			<a name="_DV_M7"></a><font style="display: inline;font-size:10pt;">(Exact name of registrant as specified in its charter)</font><br /><font style="display: inline;font-weight:bold;font-size:10pt;">_________________________</font>
		</p>
		<p style="margin:0pt;line-height:13pt;text-align:center;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;font-weight:bold;">&#xFEFF;</font>
		</p>
		<div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;margin-left:0pt;">
			<tr>
				<td valign="top" style="width:159.60pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt 6.5pt;">
					<p style="margin:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 1pt">
						<font style="display: inline;font-size:1pt;">&#xFEFF;</font><a name="_DV_M8"></a></p>
				</td>
				<td valign="top" style="width:159.60pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt 6.5pt;">
					<p style="margin:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
				<td valign="top" style="width:159.60pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt 6.5pt;">
					<p style="margin:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:159.60pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt 6.5pt;">
					<p style="margin:0pt;line-height:13pt;text-align:center;font-family:Times New Roman;font-size: 11pt">
						<font style="display: inline;font-weight:bold;font-size:11pt;">&#xFEFF;</font><font style="display: inline;font-weight:bold;font-size:11pt;">Florida</font></p>
				</td>
				<td valign="top" style="width:159.60pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt 6.5pt;">
					<p style="margin:0pt;line-height:13pt;text-align:center;font-family:Times New Roman;font-size: 11pt">
						<font style="display: inline;font-weight:bold;font-size:11pt;">1-13165</font></p>
				</td>
				<td valign="top" style="width:159.60pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt 6.5pt;">
					<p style="margin:0pt;line-height:13pt;text-align:center;font-family:Times New Roman;font-size: 11pt">
						<font style="display: inline;font-weight:bold;font-size:11pt;">59-2417093</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:159.60pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt 6.5pt;">
					<p style="margin:0pt;line-height:13pt;text-align:center;font-family:Times New Roman;font-size: 9pt">
						<font style="display: inline;font-size:9pt;">(State or Other Jurisdiction</font><br /><font style="display: inline;font-size:9pt;">of Incorporation)</font></p>
				</td>
				<td valign="top" style="width:159.60pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt 6.5pt;">
					<p style="margin:0pt;line-height:13pt;text-align:center;font-family:Times New Roman;font-size: 9pt">
						<font style="display: inline;font-size:9pt;">(Commission File Number)</font></p>
				</td>
				<td valign="top" style="width:159.60pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt 6.5pt;">
					<p style="margin:0pt;line-height:13pt;text-align:center;font-family:Times New Roman;font-size: 9pt">
						<font style="display: inline;font-size:9pt;">(IRS Employer</font></p>
					<p style="margin:0pt;line-height:13pt;text-align:center;font-family:Times New Roman;font-size: 9pt">
						<font style="display: inline;font-size:9pt;">Identification No.)</font></p>
				</td>
			</tr>
		</table></div>
		<p style="margin:0pt;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;line-height:13pt;text-align:center;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;font-weight:bold;">1655 </font><font style="display: inline;font-weight:bold;">Roberts Boulevard, N.W.</font><font style="display: inline;font-weight:bold;">, &nbsp;</font><font style="display: inline;font-weight:bold;">Kennesaw</font><font style="display: inline;font-weight:bold;">, &nbsp;</font><font style="display: inline;font-weight:bold;">Georgia</font><font style="display: inline;font-weight:bold;"> &nbsp;30144</font><br /><font style="display: inline;"></font><font style="display: inline;font-size:9pt;">(Address of principal executive office) (zip code)</font><br /><font style="display: inline;font-size:9pt;"></font>
		</p>
		<p style="margin:0pt;line-height:13pt;text-align:center;font-family:Times New Roman;font-size: 11pt">
			<a name="_DV_M9"></a><font style="display: inline;font-weight:bold;font-size:11pt;">Registrant's telephone number, including area code: (770) 419-3355</font><br /><font style="display: inline;font-weight:bold;font-size:11pt;"></font>
		</p>
		<p style="margin:0pt;line-height:13pt;text-align:center;font-family:Times New Roman;font-size: 9pt">
			<a name="_DV_M10"></a><font style="display: inline;font-size:9pt;">_____________________________________________________________</font>
		</p>
		<p style="margin:0pt;line-height:13pt;text-align:center;font-family:Times New Roman;font-size: 9pt">
			<a name="_DV_M11"></a><font style="display: inline;font-size:9pt;">(Former name or former address, if changed since last report)</font><br /><font style="display: inline;font-size:9pt;"></font>
		</p>
		<p style="margin:0pt;line-height:13pt;text-align:center;font-family:Times New Roman;font-size: 10pt">
			<a name="_DV_M12"></a><font style="display: inline;font-weight:bold;font-size:10pt;">_________________________</font>
		</p>
		<p style="margin:0pt;line-height:13pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;line-height:13pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_DV_M13"></a><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;"></font><font style="text-indent:0pt;margin-left:0pt; padding-right:4pt;text-align:left"><font style="display: inline;">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):</font></font>
		</p>
		<p style="margin:0pt;line-height:13pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt 0pt 0pt 18pt;line-height:13pt;text-indent: -18pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#x2610;</font><a name="_DV_M14"></a><font style="display: inline;font-family:Wingdings;;font-size: 12pt;font-family:Times New Roman;text-indent:0pt;margin-left:0pt;padding:0pt 18pt 0pt 0pt;"></font><font style="display: inline;">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</font>
		</p>
		<p style="margin:0pt 0pt 0pt 18pt;line-height:13pt;text-indent: -18pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt 0pt 0pt 18pt;line-height:13pt;text-indent: -18pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_DV_M15"></a><font style="display: inline;">&#x2610;</font><font style="display: inline;font-family:Wingdings;;font-size: 12pt;font-family:Times New Roman;text-indent:0pt;margin-left:0pt;padding:0pt 18pt 0pt 0pt;"></font><font style="display: inline;">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</font>
		</p>
		<p style="margin:0pt 0pt 0pt 18pt;line-height:13pt;text-indent: -18pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt 0pt 0pt 18pt;line-height:13pt;text-indent: -18pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_DV_M16"></a><font style="display: inline;">&#x2610;</font><font style="display: inline;font-family:Wingdings;;font-size: 12pt;font-family:Times New Roman;text-indent:0pt;margin-left:0pt;padding:0pt 18pt 0pt 0pt;"></font><font style="display: inline;">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</font>
		</p>
		<p style="margin:0pt 0pt 0pt 18pt;line-height:13pt;text-indent: -18pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt 0pt 0pt 18pt;line-height:13pt;text-indent: -18pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#x2610;</font><a name="_DV_M17"></a><font style="display: inline;font-family:Wingdings;;font-size: 12pt;font-family:Times New Roman;text-indent:0pt;margin-left:0pt;padding:0pt 18pt 0pt 0pt;"></font><font style="display: inline;">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</font>
		</p>
		<p style="margin:0pt;font-family:Times New Roman;font-size: 12pt">
			&nbsp;
		</p></div><div style="margin-left:72pt;margin-right:72pt;">
		<p><font size="1"> </font></p><div style="width:100%">

		<p style="margin:0pt;text-align:center;font-family:CG Omega;font-size: 12pt">

			&nbsp;

		</p>

</div><hr size="3" style="color:#999999" width="100%" align="center"></hr><p style="page-break-after:always">&nbsp;</p><div style="width:100%">

		<p style="margin:0pt;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div>
		<div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;margin-left:0pt;">
			<tr>
				<td valign="top" style="width:478.80pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt 6.5pt;">
					<p style="margin:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 1pt">
						<font style="display: inline;font-size:1pt;">&#xFEFF;</font><a name="_DV_M18"></a></p>
				</td>
			</tr>
		</table></div>
		<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;color:#000000;">&#xFEFF;</font><a name="_DV_M19"></a><a name="_DV_M20"></a>
		</p>
		<div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;margin-left:0pt;">
			<tr>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;width:77.40pt;height:1.00pt;padding:0pt 6.5pt">
					<p style="margin:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 1pt">
						<font style="display: inline;font-size:1pt;">&#xFEFF;</font></p>
				</td>
				<td valign="top" style="border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;width:401.40pt;height:1.00pt;padding:0pt 6.5pt">
					<p style="margin:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;width:77.40pt;padding:0pt 6.5pt">
					<p style="margin:0pt;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;font-weight:bold;">Section 5</font></p>
				</td>
				<td valign="top" style="border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;width:401.40pt;padding:0pt 6.5pt">
					<p style="margin:0pt;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;font-weight:bold;color:#000000;">Corp. Governance and Management</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;width:77.40pt;padding:0pt 6.5pt">
					<p style="margin:0pt;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;font-weight:bold;">&#xFEFF;</font></p>
				</td>
				<td valign="top" style="border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;width:401.40pt;padding:0pt 6.5pt">
					<p style="margin:0pt;font-family:Times New Roman;font-size: 12pt">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;width:77.40pt;padding:0pt 6.5pt">
					<p style="margin:0pt;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;font-weight:bold;">Item 5.02</font></p>
				</td>
				<td valign="top" style="border-left:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;width:401.40pt;padding:0pt 6.5pt">
					<p style="margin:0pt;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;font-weight:bold;color:#000000;">Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.</font></p>
				</td>
			</tr>
		</table></div>
		<p style="margin:0pt;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;;font-size: 12pt;font-family:Times New Roman;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display: inline;font-weight:bold;color:#000000;"></font><font style="display: inline;color:#000000;">On </font><font style="display: inline;color:#000000;">September 29</font><font style="display: inline;color:#000000;">, 2017</font><font style="display: inline;color:#000000;">, the Board of Directors (the &#x201C;Board&#x201D;) of CryoLife, Inc. a Florida corporation (NYSE: CRY) (the &#x201C;Company&#x201D;) increased the size of the Company&#x2019;s Board to nine members and elected </font><font style="display: inline;color:#000000;">Jeffrey H</font><font style="display: inline;color:#000000;">. Bu</font><font style="display: inline;color:#000000;">rbank</font><font style="display: inline;color:#000000;">&nbsp;</font><font style="display: inline;color:#000000;">as a director of the Company. Mr. </font><font style="display: inline;color:#000000;">Burbank </font><font style="display: inline;color:#000000;">will be included </font><font style="display: inline;color:#000000;">as one of</font><font style="display: inline;color:#000000;"> the Company&#x2019;s directors who will stand for reelection by the Company&#x2019;s shareholders at the Company&#x2019;s Annual Meeting to be held in May 201</font><font style="display: inline;color:#000000;">8</font><font style="display: inline;color:#000000;">. On </font><font style="display: inline;color:#000000;">October 2, 201</font><font style="display: inline;color:#000000;">7</font><font style="display: inline;color:#000000;">,</font><font style="display: inline;color:#000000;"> the Company issued a press release regarding Mr. </font><font style="display: inline;color:#000000;">Burbank&#x2019;s </font><font style="display: inline;color:#000000;">appointment, a copy of which is attached hereto. </font>
		</p>
		<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;color:#000000;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;color:#000000;;font-size: 12pt;font-family:Times New Roman;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display: inline;color:#000000;">The Board has affirmatively determined the Mr. </font><font style="display: inline;color:#000000;">Burbank </font><font style="display: inline;color:#000000;">qualifies </font><font style="display: inline;color:#000000;">as an independent director under the categorical standards of the corporate governance rules of New York Stock Exchange as defined under applicable law. </font>
		</p>
		<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;color:#000000;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;color:#000000;">There are no arrangements or understandings between Mr. </font><font style="display: inline;color:#000000;">Burbank </font><font style="display: inline;color:#000000;">and any person pursuant to </font><font style="display: inline;color:#000000;">which Mr. </font><font style="display: inline;color:#000000;">Burbank </font><font style="display: inline;color:#000000;">was selected as a director, and there are no actual or proposed transactions between Mr. </font><font style="display: inline;color:#000000;">Burbank </font><font style="display: inline;color:#000000;">or any of his related persons and the Company that would require disclosure under Item 404(a) of Regulation S-K (17 CFR 229.404(a)) in connection with his appointment as a director of the Company.</font>
		</p>
		<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;color:#000000;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;color:#000000;">As of the date of his appointment, Mr. </font><font style="display: inline;color:#000000;">Burbank </font><font style="display: inline;color:#000000;">is entitled to receive compensation and participate in the plans of the Company applicable to all of the Company&#x2019;s directors, as more particularly described on </font><font style="display: inline;color:#000000;">page</font><font style="display: inline;color:#000000;"> &nbsp;1</font><font style="display: inline;color:#000000;">7</font><font style="display: inline;color:#000000;"> of the Comp</font><font style="display: inline;color:#000000;">any&#x2019;s proxy statement filed </font><font style="display: inline;color:#000000;">March 28, 2017</font><font style="display: inline;color:#000000;">, under th</font><font style="display: inline;color:#000000;">e sub-heading &#x201C;Elements of Non-Employee Director Compensation</font><font style="display: inline;color:#000000;">&#x201D;</font><font style="display: inline;color:#000000;">. In accordance with such plans, </font><font style="display: inline;color:#000000;">Mr. </font><font style="display: inline;color:#000000;">Burbank </font><font style="display: inline;color:#000000;">will be</font><font style="display: inline;color:#000000;">&nbsp;</font><font style="display: inline;color:#000000;">granted,</font><font style="display: inline;color:#000000;">&nbsp;</font><font style="display: inline;color:#000000;">as soon as practicable after any applicable trading blackout has been lifted, </font><font style="display: inline;color:#000000;">a restricted stock award value</font><font style="display: inline;color:#000000;">d at $</font><font style="display: inline;color:#000000;">67,000</font><font style="display: inline;color:#000000;"> on the grant date</font><font style="display: inline;color:#000000;">, such award to vest </font><font style="display: inline;color:#000000;">one year front grant</font><font style="display: inline;color:#000000;">.</font><font style="display: inline;color:#000000;">&nbsp;</font><font style="display: inline;color:#000000;">I</font><font style="display: inline;color:#000000;">n addition</font><font style="display: inline;color:#000000;">,</font><font style="display: inline;color:#000000;">&nbsp;</font><font style="display: inline;color:#000000;">commencing on </font><font style="display: inline;color:#000000;">October</font><font style="display: inline;color:#000000;">&nbsp;</font><font style="display: inline;color:#000000;">1, 201</font><font style="display: inline;color:#000000;">7</font><font style="display: inline;color:#000000;">, Mr.</font><font style="display: inline;color:#000000;">&nbsp;</font><font style="display: inline;color:#000000;">Burbank </font><font style="display: inline;color:#000000;">will receive monthly cash compensation for </font><font style="display: inline;color:#000000;">his </font><font style="display: inline;color:#000000;">service on the Board ($3,333.33/month) </font><font style="display: inline;color:#000000;">and </font><font style="display: inline;color:#000000;">for his</font><font style="display: inline;color:#000000;"> service on the Corporate Governance Committee </font><font style="display: inline;color:#000000;">($</font><font style="display: inline;color:#000000;">625</font><font style="display: inline;color:#000000;">/</font><font style="display: inline;color:#000000;">month</font><font style="display: inline;color:#000000;">) &nbsp;</font><font style="display: inline;color:#000000;">until such time as the Company&#x2019;s </font><font style="display: inline;color:#000000;">Board</font><font style="display: inline;color:#000000;"> determine</font><font style="display: inline;color:#000000;">s</font><font style="display: inline;color:#000000;"> to modify the cash component for director compensation</font><font style="display: inline;color:#000000;"> or committee membership</font><font style="display: inline;color:#000000;"> or Mr. </font><font style="display: inline;color:#000000;">Burbank </font><font style="display: inline;color:#000000;">ceases to be a director</font><font style="display: inline;color:#000000;"> or to serve on the Corporate Governance Committee</font><font style="display: inline;color:#000000;">. Each of the foregoing awards was made in respect of, and prorated to, Mr. </font><font style="display: inline;color:#000000;">Burbank&#x2019;s </font><font style="display: inline;color:#000000;">service from the date of his appointment until the anticipated date of the Company&#x2019;s next Annual Meeting. </font>
		</p>
		<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;color:#000000;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;color:#000000;">Except as set forth above, there is no other material Company plan, contract or arrangement in which Mr. </font><font style="display: inline;color:#000000;">Burbank </font><font style="display: inline;color:#000000;">will participate in connection with his appointment. </font>
		</p>
		<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;color:#000000;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;color:#000000;;font-size: 12pt;font-family:Times New Roman;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display: inline;color:#000000;"></font><font style="display: inline;color:#000000;"> &nbsp; &nbsp;</font><font style="display: inline;color:#000000;">&nbsp;</font>
		</p>
		<p style="margin:0pt;font-family:Times New Roman;font-size: 12pt">

		</p>
		<p><font size="1"> </font></p><div style="width:100%">

		<p style="margin:0pt;font-family:CG Omega;font-size: 12pt">

			&nbsp;

		</p>

</div><hr size="3" style="color:#999999" width="100%" align="center"></hr><p style="page-break-after:always">&nbsp;</p><div style="width:100%">

		<p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

		<p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div>
		<p style="margin:0pt;font-family:Times New Roman;;font-size: 12pt"><font style="display: inline;color:#000000;"></font><font style="display: inline;font-weight:bold;">Section 9</font><font style="display: inline;font-weight:bold;;font-size: 12pt;font-family:Times New Roman;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display: inline;font-weight:bold;">Financial Statements and Exhibits.</font>
		</p>
		<p style="margin:0pt;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;font-weight:bold;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;font-weight:bold;">Item 9.01(d)</font><font style="display: inline;font-weight:bold;;font-size: 12pt;font-family:Times New Roman;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display: inline;font-weight:bold;">Exhibits</font>
		</p>
		<p style="margin:0pt;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">(a)</font><font style="display: inline;;font-size: 12pt;font-family:Times New Roman;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display: inline;">Financial Statements</font>
		</p>
		<p style="margin:0pt;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;;font-size: 12pt;font-family:Times New Roman;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display: inline;">Not applicable</font>
		</p>
		<p style="margin:0pt;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">(b)</font><font style="display: inline;;font-size: 12pt;font-family:Times New Roman;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display: inline;">Pro Forma Financial Information.</font>
		</p>
		<p style="margin:0pt;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;;font-size: 12pt;font-family:Times New Roman;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display: inline;">Not applicable.</font>
		</p>
		<p style="margin:0pt;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">(c)</font><font style="display: inline;;font-size: 12pt;font-family:Times New Roman;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display: inline;">Shell Company Transactions.</font>
		</p>
		<p style="margin:0pt;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;;font-size: 12pt;font-family:Times New Roman;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display: inline;">Not applicable.</font>
		</p>
		<p style="margin:0pt;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">(d)</font><font style="display: inline;;font-size: 12pt;font-family:Times New Roman;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display: inline;">Exhibits.</font>
		</p>
		<p style="margin:0pt;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#xFEFF;</font>
		</p>
		<div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;margin-left:0pt;">
			<tr>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;width:117.90pt;height:1.00pt;padding:0pt 6.5pt">
					<p style="margin:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 1pt">
						<font style="display: inline;font-size:1pt;">&#xFEFF;</font></p>
				</td>
				<td valign="top" style="border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;width:239.40pt;height:1.00pt;padding:0pt 6.5pt">
					<p style="margin:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;width:117.90pt;padding:0pt 6.5pt">
					<p style="margin:0pt;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;">Exhibit Number</font></p>
				</td>
				<td valign="top" style="border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;width:239.40pt;padding:0pt 6.5pt">
					<p style="margin:0pt;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;">Description</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="border-right:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;width:117.90pt;padding:0pt 6.5pt">
					<p style="margin:0pt;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;">99.1*</font></p>
				</td>
				<td valign="top" style="border-left:1pt none #D9D9D9 ;border-top:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;width:239.40pt;padding:0pt 6.5pt">
					<p style="margin:0pt;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;">Press release dated October 2, 201</font><font style="display: inline;">7</font></p>
				</td>
			</tr>
		</table></div>
		<p style="margin:0pt;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">*This exhibit is furnished, not filed.</font>
		</p>
		<p style="margin:0pt;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;font-weight:bold;">&#xFEFF;</font><a name="_DV_M30"></a><a name="_DV_M38"></a>
		</p>
		<p style="margin:0pt 0pt 0pt 144pt;text-indent: -108pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 12pt">

		</p>
		<p><font size="1"> </font></p><div style="width:100%">

		<p style="margin:0pt;text-align:center;font-family:CG Omega;font-size: 12pt">

			&nbsp;

		</p>

		<p style="margin:0pt;font-family:CG Omega;font-size: 12pt">

			&nbsp;

		</p>

</div><hr size="3" style="color:#999999" width="100%" align="center"></hr><p style="page-break-after:always">&nbsp;</p><div style="width:100%">

		<p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

		<p style="margin:0pt;text-align:right;font-family:Times New Roman;font-size: 12pt">

			&nbsp;

		</p>

</div>
		<p style="margin:0pt;text-align:center;font-family:Times New Roman;;font-size: 12pt"><font style="display: inline;font-weight:bold;"></font><font style="display: inline;font-weight:bold;">SIGNATURES</font>
		</p>
		<p style="margin:0pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<a name="_DV_M39"></a><br /><font style="display: inline;"></font><font style="display: inline;;font-size: 12pt;font-family:Times New Roman;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display: inline;">Pursuant to the requirements of the Securities Exchange Act of 1934, CryoLife, Inc. has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</font>
		</p>
		<p style="margin:0pt;text-indent:36pt;text-align:justify;text-justify:inter-ideograph;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;text-align:center;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#xFEFF;</font>
		</p>
		<div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;margin-left:0pt;">
			<tr>
				<td valign="top" style="width:239.40pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt 6.5pt;">
					<p style="margin:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size: 1pt">
						<font style="display: inline;font-size:1pt;">&#xFEFF;</font></p>
				</td>
				<td colspan="2" valign="top" style="width:239.40pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt 6.5pt;">
					<p style="margin:0pt;font-family:Times New Roman;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:239.40pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt 6.5pt;">
					<p style="margin:0pt;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;">&#xFEFF;</font></p>
				</td>
				<td colspan="2" valign="top" style="width:239.40pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt 6.5pt;">
					<p style="margin:0pt;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;">CRYOLIFE, INC.</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:239.40pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt 6.5pt;">
					<p style="margin:0pt;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;">&#xFEFF;</font></p>
				</td>
				<td colspan="2" valign="top" style="width:239.40pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt 6.5pt;">
					<p style="margin:0pt;font-family:Times New Roman;font-size: 12pt">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:239.40pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt 6.5pt;">
					<p style="margin:0pt;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;">&#xFEFF;</font></p>
				</td>
				<td colspan="2" valign="top" style="width:239.40pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt 6.5pt;">
					<p style="margin:0pt;font-family:Times New Roman;font-size: 12pt">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:239.40pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt 6.5pt;">
					<p style="margin:0pt;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;">Date:&nbsp;&nbsp;October 2, 2017</font></p>
				</td>
				<td valign="top" style="width:45.00pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt 6.5pt;">
					<p style="margin:0pt;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;">By: </font></p>
				</td>
				<td valign="top" style="width:194.40pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt 6.5pt;">
					<p style="margin:0pt;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;text-decoration:underline;">/s/ D. Ashley Lee</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:239.40pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt 6.5pt;">
					<p style="margin:0pt;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;">&#xFEFF;</font></p>
				</td>
				<td valign="top" style="width:45.00pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt 6.5pt;">
					<p style="margin:0pt;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;">Name:&nbsp; </font></p>
				</td>
				<td valign="top" style="width:194.40pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt 6.5pt;">
					<p style="margin:0pt;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;">D. Ashley Lee</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:239.40pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt 6.5pt;">
					<p style="margin:0pt;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;">&#xFEFF;</font></p>
				</td>
				<td valign="top" style="width:45.00pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt 6.5pt;">
					<p style="margin:0pt;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;">Title:&nbsp; </font></p>
				</td>
				<td valign="top" style="width:194.40pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;padding:0pt 6.5pt;">
					<p style="margin:0pt;font-family:Times New Roman;font-size: 12pt">
						<font style="display: inline;">Executive Vice President, Chief&nbsp;&nbsp;&nbsp;&nbsp;Operating Officer and Chief Financial Officer&nbsp; </font></p>
				</td>
			</tr>
		</table></div>
		<p style="margin:0pt;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;font-family:Times New Roman;font-size: 12pt">
			<font style="display: inline;">&#xFEFF;</font>
		</p>
		<p><font size="1"> </font></p><div style="width:100%">

		<p style="margin:0pt;text-align:center;font-family:CG Omega;font-size: 12pt">

			&nbsp;

		</p>

		<p style="margin:0pt;font-family:CG Omega;font-size: 12pt">

			&nbsp;

		</p>

</div><hr size="3" style="color:#999999" width="100%" align="center"></hr>
	</div></body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>c199-20171002xex99_1.htm
<DESCRIPTION>EX-99.1
<TEXT>
<!--HTML document created with Certent Disclosure Management 6.10.0.3-->
<!--Created on: 10/2/2017 8:31:33 AM-->
<html>
	<head>
		<title>
			20171002 8K Burbank Exhibit 991
		</title>
	</head>
	<body><div style="margin-left:72pt;margin-right:72pt;"><div style="width:100%">

		<p style="margin:0pt;text-align:right;line-height:100%;font-family:Calibri;font-size: 11pt">

			<font style="display: inline;font-family:Times New Roman;">Exhibit 99.1</font>

		</p>

</div>
		<p style="margin:0pt;line-height:100%;text-align:center;font-family:Calibri;font-size: 12pt">
			<a name="_GoBack"></a><font style="display: inline;font-family:Times New Roman;font-size:12pt;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;line-height:100%;text-align:center;font-family:Calibri;font-size: 12pt">
			<font style="display: inline;font-family:Times New Roman;font-size:12pt;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;line-height:150%;font-family:Calibri;font-size: 12pt">
			<a name="_DV_M0"></a><a name="_DV_M4"></a><font style="display: inline;font-family:Times New Roman;font-weight:bold;font-style:italic;color:#000000;font-size:12pt;">FOR IMMEDIATE RELEASE </font>
		</p>
		<p style="margin:0pt;line-height:100%;font-family:Calibri;font-size: 12pt">
			<br /><font style="display: inline;font-family:Times New Roman;font-weight:bold;color:#000000;font-size:12pt;">Contacts:</font>
		</p>
		<p style="margin:0pt;line-height:100%;font-family:Calibri;font-size: 12pt">
			<font style="display: inline;font-family:Times New Roman;font-weight:bold;color:#000000;font-size:12pt;">&#xFEFF;</font>
		</p>
		<div style="width:100%"><table cellpadding="0" cellspacing="0" style="border-collapse:collapse;margin-left:0pt;">
			<tr>
				<td valign="top" style="width:261.90pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt 6.5pt;">
					<p style="margin:0pt;line-height:100%;font-family:Calibri;height:1.00pt;overflow:hidden">
						<font style="display: inline;font-family:Times New Roman;font-weight:bold;color:#000000;font-size:12pt;;font-size: 12pt;font-family:Calibri;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display: inline;font-family:Times New Roman;color:#000000;font-size:12pt;"></font><font style="display: inline;font-family:Times New Roman;color:#000000;font-size:12pt;;font-size: 12pt;font-family:Calibri;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display: inline;font-family:Times New Roman;color:#000000;font-size:12pt;"></font><font style="display: inline;font-family:Times New Roman;color:#000000;font-size:12pt;;font-size: 12pt;font-family:Calibri;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display: inline;font-family:Times New Roman;color:#000000;font-size:12pt;"></font><font style="display: inline;font-family:Times New Roman;color:#000000;font-size:12pt;;font-size: 12pt;font-family:Calibri;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display: inline;font-family:Times New Roman;color:#000000;font-size:12pt;"></font><font style="display: inline;font-family:Times New Roman;color:#000000;font-size:12pt;"></font></p>
					<p style="margin:0pt;line-height:100%;font-family:Calibri;height:1.00pt;overflow:hidden;font-size: 12pt">
						<font style="display: inline;font-family:Times New Roman;color:#000000;font-size:12pt;;font-size: 12pt;font-family:Calibri;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display: inline;font-family:Times New Roman;color:#000000;font-size:12pt;"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Phone: 770-419-3355</font></p>
					<p style="margin:0pt;font-family:Calibri;line-height:115%;height:1.00pt;overflow:hidden">
						&nbsp;</p>
				</td>
				<td valign="top" style="width:210.90pt;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt none #D9D9D9 ;border-right:1pt none #D9D9D9 ;height:1.00pt;padding:0pt 6.5pt;">
					<p style="margin:0pt;line-height:100%;font-family:Calibri;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
					<p style="margin:0pt;line-height:100%;font-family:Calibri;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
					<p style="margin:0pt;line-height:100%;font-family:Calibri;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
					<p style="margin:0pt;font-family:Calibri;line-height:115%;height:1.00pt;overflow:hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:261.90pt;height:14.95pt;padding:0pt 6.5pt;">
					<p style="margin:0pt;line-height:100%;font-family:Calibri;font-size: 12pt">
						<font style="display: inline;font-family:Times New Roman;font-weight:bold;color:#000000;font-size:12pt;">CryoLife </font><font style="display: inline;font-family:Times New Roman;font-weight:bold;color:#000000;font-size:12pt;;font-size: 12pt;font-family:Calibri;text-indent:0pt;margin-left:0pt;padding:0pt 36pt 0pt 0pt;"></font><font style="display: inline;font-family:Times New Roman;font-weight:bold;color:#000000;font-size:12pt;"></font><font style="display: inline;font-family:Times New Roman;color:#000000;font-size:12pt;"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></p>
				</td>
				<td valign="top" style="width:210.90pt;height:14.95pt;padding:0pt 6.5pt;">
					<p style="margin:0pt;line-height:100%;font-family:Calibri;font-size: 12pt">
						<font style="display: inline;font-family:Times New Roman;font-weight:bold;color:#000000;font-size:12pt;">The Ruth Group</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:261.90pt;height:14.85pt;padding:0pt 6.5pt;">
					<p style="margin:0pt;line-height:100%;font-family:Calibri;font-size: 12pt">
						<font style="display: inline;font-family:Times New Roman;color:#000000;font-size:12pt;">D. Ashley Lee</font><font style="display: inline;font-family:Times New Roman;color:#000000;font-size:12pt;"></font></p>
				</td>
				<td valign="top" style="width:210.90pt;height:14.85pt;padding:0pt 6.5pt;">
					<p style="margin:0pt;line-height:100%;font-family:Calibri;font-size: 12pt">
						<font style="display: inline;font-family:Times New Roman;color:#000000;font-size:12pt;">Zack Kubow</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:261.90pt;height:14.85pt;padding:0pt 6.5pt;">
					<p style="margin:0pt;line-height:100%;font-family:Calibri;font-size: 12pt">
						<font style="display: inline;font-family:Times New Roman;color:#000000;font-size:12pt;">Executive Vice President, Chief Financial Officer and Chief Operating Officer</font></p>
				</td>
				<td valign="top" style="width:210.90pt;height:14.85pt;padding:0pt 6.5pt;">
					<p style="margin:0pt;line-height:100%;font-family:Calibri;font-size: 12pt">
						<font style="display: inline;font-family:Times New Roman;color:#000000;font-size:12pt;">646-536-7020</font></p>
					<p style="margin:0pt;line-height:100%;font-family:Calibri;font-size: 12pt">
						<font style="display: inline;font-family:Times New Roman;color:#000000;font-size:12pt;text-decoration:underline;">zkubow@theruthgroup.com</font></p>
				</td>
			</tr>
			<tr>
				<td valign="top" style="width:261.90pt;height:14.85pt;padding:0pt 6.5pt;">
					<p style="margin:0pt;line-height:100%;font-family:Calibri;font-size: 12pt">
						<font style="display: inline;font-family:Times New Roman;color:#000000;font-size:12pt;">Phone: 770-419-3355</font></p>
				</td>
				<td valign="top" style="width:210.90pt;height:14.85pt;padding:0pt 6.5pt;">
					<p style="margin:0pt;line-height:100%;font-family:Calibri;overflow: hidden;font-size:0pt;">
						&nbsp;</p>
				</td>
			</tr>
		</table></div>
		<p style="margin:0pt 0pt 10pt;font-family:Calibri;line-height:115%;font-size: 11pt">
			<font style="display: inline;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt 0pt 10pt;text-align:center;font-family:Calibri;line-height:115%;font-size: 14pt">
			<font style="display: inline;font-family:Times New Roman;font-weight:bold;font-size:14pt;">Jeffrey H. Burbank</font><font style="display: inline;font-family:Times New Roman;font-weight:bold;font-size:14pt;">&nbsp;</font><font style="display: inline;font-family:Times New Roman;font-weight:bold;font-size:14pt;">Join</font><font style="display: inline;font-family:Times New Roman;font-weight:bold;font-size:14pt;">s</font><font style="display: inline;font-family:Times New Roman;font-weight:bold;font-size:14pt;"> CryoLife </font><font style="display: inline;font-family:Times New Roman;font-weight:bold;font-size:14pt;">Board of Directors</font>
		</p>
		<p style="margin:0pt 0pt 10pt;text-align:justify;text-justify:inter-ideograph;font-family:Calibri;line-height:115%;font-size: 12pt">
			<font style="display: inline;font-family:Times New Roman;font-size:12pt;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt 0pt 10pt;text-align:justify;text-justify:inter-ideograph;font-family:Calibri;line-height:115%;font-size: 12pt">
			<font style="display: inline;font-family:Times New Roman;font-weight:bold;font-size:12pt;">ATLANTA, </font><font style="display: inline;font-family:Times New Roman;font-weight:bold;font-size:12pt;">GA&#x2026;(</font><font style="display: inline;font-family:Times New Roman;font-weight:bold;font-size:12pt;">October 2</font><font style="display: inline;font-family:Times New Roman;font-weight:bold;font-size:12pt;">,</font><font style="display: inline;font-family:Times New Roman;font-weight:bold;font-size:12pt;"> 201</font><font style="display: inline;font-family:Times New Roman;font-weight:bold;font-size:12pt;">7</font><font style="display: inline;font-family:Times New Roman;font-weight:bold;font-size:12pt;">)&#x2026;</font><font style="display: inline;font-family:Times New Roman;font-weight:bold;font-size:12pt;">CryoLife, Inc. (NYSE: CRY),</font><font style="display: inline;font-family:Times New Roman;font-size:12pt;"> a leading medical device and tissue processing company focused on cardiac</font><font style="display: inline;font-family:Times New Roman;font-size:12pt;">&nbsp;</font><font style="display: inline;font-family:Times New Roman;font-size:12pt;">and vascular </font><font style="display: inline;font-family:Times New Roman;font-size:12pt;">surgery</font><font style="display: inline;font-family:Times New Roman;font-size:12pt;">, announced </font><font style="display: inline;font-family:Times New Roman;font-size:12pt;">the appointment </font><font style="display: inline;font-family:Times New Roman;font-size:12pt;">of </font><font style="display: inline;font-family:Times New Roman;font-size:12pt;">Jeffrey H. Burbank</font><font style="display: inline;font-family:Times New Roman;font-size:12pt;"> to </font><font style="display: inline;font-family:Times New Roman;font-size:12pt;">its Board of Directors</font><font style="display: inline;font-family:Times New Roman;font-size:12pt;"> effective September 29, 2017</font><font style="display: inline;font-family:Times New Roman;font-size:12pt;">. &nbsp;</font>
		</p>
		<p style="margin:0pt 0pt 10pt;text-align:justify;text-justify:inter-ideograph;font-family:Calibri;line-height:115%;font-size: 12pt">
			<font style="display: inline;font-family:Times New Roman;font-size:12pt;">Pat Mackin, Chairman, President, and Chief Executive Officer</font><font style="display: inline;font-family:Times New Roman;font-size:12pt;">, &nbsp;</font><font style="display: inline;font-family:Times New Roman;font-size:12pt;">commented</font><font style="display: inline;font-family:Times New Roman;font-size:12pt;">, &nbsp;</font><font style="display: inline;font-family:Times New Roman;font-size:12pt;">&#x201C;</font><font style="display: inline;font-family:Times New Roman;font-size:12pt;">Jeff </font><font style="display: inline;font-family:Times New Roman;font-size:12pt;">has over 30 years of in-depth management experience</font><font style="display: inline;font-family:Times New Roman;font-size:12pt;"> in medical devices, highlighted by his tenure growing NxStage Medical</font><font style="display: inline;font-family:Times New Roman;font-size:12pt;"> from inception to more than $</font><font style="display: inline;font-family:Times New Roman;font-size:12pt;">360 </font><font style="display: inline;font-family:Times New Roman;font-size:12pt;">million in </font><font style="display: inline;font-family:Times New Roman;font-size:12pt;">annual </font><font style="display: inline;font-family:Times New Roman;font-size:12pt;">revenue</font><font style="display: inline;font-family:Times New Roman;font-size:12pt;">.&nbsp; </font><font style="display: inline;font-family:Times New Roman;font-size:12pt;">His experience</font><font style="display: inline;font-family:Times New Roman;font-size:12pt;"> will</font><font style="display: inline;font-family:Times New Roman;font-size:12pt;"> allow him to bring</font><font style="display: inline;font-family:Times New Roman;font-size:12pt;"> a </font><font style="display: inline;font-family:Times New Roman;font-size:12pt;">unique</font><font style="display: inline;font-family:Times New Roman;font-size:12pt;"> perspective</font><font style="display: inline;font-family:Times New Roman;font-size:12pt;">&nbsp;</font><font style="display: inline;font-family:Times New Roman;font-size:12pt;">to our Board </font><font style="display: inline;font-family:Times New Roman;font-size:12pt;">on our internal </font><font style="display: inline;font-family:Times New Roman;font-size:12pt;">and external </font><font style="display: inline;font-family:Times New Roman;font-size:12pt;">development programs</font><font style="display: inline;font-family:Times New Roman;font-size:12pt;">.</font><font style="display: inline;font-family:Times New Roman;font-size:12pt;">&nbsp;</font><font style="display: inline;font-family:Times New Roman;font-size:12pt;">&nbsp;</font><font style="display: inline;font-family:Times New Roman;font-size:12pt;">Jeff brings a proven track record of success to the Board as we continue to focus on accelerating the Company&#x2019;s growth</font><font style="display: inline;font-family:Times New Roman;font-size:12pt;">.&#x201D;</font>
		</p>
		<p style="margin:0pt 0pt 10pt;text-align:justify;text-justify:inter-ideograph;font-family:Calibri;line-height:115%;font-size: 12pt">
			<font style="display: inline;font-family:Times New Roman;font-size:12pt;">Mr. Burbank</font><font style="display: inline;font-family:Times New Roman;font-size:12pt;"> said, &#x201C;I am excited to</font><font style="display: inline;font-family:Times New Roman;font-size:12pt;">&nbsp;</font><font style="display: inline;font-family:Times New Roman;font-size:12pt;">join the </font><font style="display: inline;font-family:Times New Roman;font-size:12pt;">CryoLife </font><font style="display: inline;font-family:Times New Roman;font-size:12pt;">Board of Directors. </font><font style="display: inline;font-family:Times New Roman;font-size:12pt;">&nbsp;</font><font style="display: inline;font-family:Times New Roman;font-size:12pt;">I share </font><font style="display: inline;font-family:Times New Roman;font-size:12pt;">the </font><font style="display: inline;font-family:Times New Roman;font-size:12pt;">Company&#x2019;s vision</font><font style="display: inline;font-family:Times New Roman;font-size:12pt;"> to </font><font style="display: inline;font-family:Times New Roman;font-size:12pt;">advance the standard of care with innovative products that </font><font style="display: inline;font-family:Times New Roman;font-size:12pt;">help improve the health and quality of life of patients</font><font style="display: inline;font-family:Times New Roman;font-size:12pt;">.</font><font style="display: inline;font-family:Times New Roman;font-size:12pt;"> &nbsp; &nbsp;</font><font style="display: inline;font-family:Times New Roman;font-size:12pt;">I &nbsp;</font><font style="display: inline;font-family:Times New Roman;font-size:12pt;">look forward to working with </font><font style="display: inline;font-family:Times New Roman;font-size:12pt;">Pat</font><font style="display: inline;font-family:Times New Roman;font-size:12pt;">, the Board</font><font style="display: inline;font-family:Times New Roman;font-size:12pt;"> and </font><font style="display: inline;font-family:Times New Roman;font-size:12pt;">the</font><font style="display: inline;font-family:Times New Roman;font-size:12pt;"> CryoLife team</font><font style="display: inline;font-family:Times New Roman;font-size:12pt;"> as they continue to</font><font style="display: inline;font-family:Times New Roman;font-size:12pt;">&nbsp;</font><font style="display: inline;font-family:Times New Roman;font-size:12pt;">advance the</font><font style="display: inline;font-family:Times New Roman;font-size:12pt;"> Company&#x2019;s </font><font style="display: inline;font-family:Times New Roman;font-size:12pt;">mission.</font><font style="display: inline;font-family:Times New Roman;font-size:12pt;">&#x201D;</font><font style="display: inline;font-family:Times New Roman;font-size:12pt;">&nbsp;</font><font style="display: inline;font-family:Times New Roman;font-size:12pt;">&nbsp;</font><font style="display: inline;font-family:Times New Roman;font-size:12pt;">&nbsp;</font>
		</p>
		<p style="margin:0pt 0pt 10pt;text-align:justify;text-justify:inter-ideograph;font-family:Calibri;line-height:115%;font-size: 12pt">
			<font style="display: inline;font-family:Times New Roman;font-size:12pt;">Mr. </font><font style="display: inline;font-family:Times New Roman;font-size:12pt;">Burbank</font><font style="display: inline;font-family:Times New Roman;font-size:12pt;"> is</font><font style="display: inline;font-family:Times New Roman;font-size:12pt;">&nbsp;</font><font style="display: inline;font-family:Times New Roman;font-size:12pt;">the</font><font style="display: inline;font-family:Times New Roman;font-size:12pt;">&nbsp;</font><font style="display: inline;font-family:Times New Roman;font-size:12pt;">C</font><font style="display: inline;font-family:Times New Roman;font-size:12pt;">hief Executive Officer</font><font style="display: inline;font-family:Times New Roman;font-size:12pt;"> and </font><font style="display: inline;font-family:Times New Roman;font-size:12pt;">founder</font><font style="display: inline;font-family:Times New Roman;font-size:12pt;"> of </font><font style="display: inline;font-family:Times New Roman;font-size:12pt;">NxStage Medical</font><font style="display: inline;font-family:Times New Roman;font-size:12pt;">, &nbsp;</font><font style="display: inline;font-family:Times New Roman;font-size:12pt;">Inc.</font><font style="display: inline;font-family:Times New Roman;font-size:12pt;">, &nbsp;</font><font style="display: inline;font-family:Times New Roman;font-size:12pt;">(NASDAQ: NXTM) a leading medical technology company that develops, manufactures and markets innovative products for the treatment of end-stage renal disease (E</font><font style="display: inline;font-family:Times New Roman;font-size:12pt;">SRD</font><font style="display: inline;font-family:Times New Roman;font-size:12pt;">) and acute kidney failure.</font><font style="display: inline;font-family:Times New Roman;font-size:12pt;">&nbsp;</font><font style="display: inline;font-family:Times New Roman;font-size:12pt;">&nbsp;</font><font style="display: inline;font-family:Times New Roman;font-size:12pt;">Mr. Burbank </font><font style="display: inline;font-family:Times New Roman;font-size:11.5pt;background-color: #FFFFFF;">has led NxStage since its inception in 1998, guiding it through all of its developmental phases to the successful initiation and rapid growth of commercial activities, its initial public offering, the evolution of its product line, its expansion into other markets</font><font style="display: inline;font-family:Times New Roman;font-size:11.5pt;background-color: #FFFFFF;">, and its pending acquisition by Fresenius Medical Care</font><font style="display: inline;font-family:Times New Roman;font-size:11.5pt;background-color: #FFFFFF;">.</font><font style="display: inline;font-family:Times New Roman;font-size:12pt;">&nbsp;</font><font style="display: inline;font-family:Times New Roman;font-size:12pt;">&nbsp;</font><font style="display: inline;font-family:Times New Roman;font-size:12pt;">Prior to </font><font style="display: inline;font-family:Times New Roman;font-size:12pt;">N</font><font style="display: inline;font-family:Times New Roman;font-size:12pt;">xStage, </font><font style="display: inline;font-family:Times New Roman;font-size:12pt;">Mr. Bu</font><font style="display: inline;font-family:Times New Roman;font-size:12pt;">rbank</font><font style="display: inline;font-family:Times New Roman;font-size:12pt;"> was </font><font style="display: inline;font-family:Times New Roman;font-size:12pt;">Chairman and</font><font style="display: inline;font-family:Times New Roman;font-size:12pt;">&nbsp;</font><font style="display: inline;font-family:Times New Roman;font-size:12pt;">Chief Executive Officer</font><font style="display: inline;font-family:Times New Roman;font-size:12pt;">&nbsp;</font><font style="display: inline;font-family:Times New Roman;font-size:12pt;">of Vasc</font><font style="display: inline;font-family:Times New Roman;font-size:12pt;">a</font><font style="display: inline;font-family:Times New Roman;font-size:12pt;">, Inc., a privately held, medical device company</font><font style="display: inline;font-family:Times New Roman;font-size:12pt;">.</font><font style="display: inline;font-family:Times New Roman;font-size:12pt;">&nbsp;</font><font style="display: inline;font-family:Times New Roman;font-size:12pt;">&nbsp;</font><font style="display: inline;font-family:Times New Roman;font-size:12pt;">Mr</font><font style="display: inline;font-family:Times New Roman;font-size:12pt;">. &nbsp;</font><font style="display: inline;font-family:Times New Roman;font-size:12pt;">Burbank previously held leadership positions at ZymeQuest, Inc., and Gambro, Inc</font><font style="display: inline;font-family:Times New Roman;font-size:12pt;">.&nbsp; </font><font style="display: inline;font-family:Times New Roman;font-size:12pt;">Mr. Burbank</font><font style="display: inline;font-family:Times New Roman;font-size:12pt;"> received his Bachelor</font><font style="display: inline;font-family:Times New Roman;font-size:12pt;"> of Science</font><font style="display: inline;font-family:Times New Roman;font-size:12pt;"> in </font><font style="display: inline;font-family:Times New Roman;font-size:12pt;">Industrial Engineering from Lehigh University. </font>
		</p>
		<p style="margin:0pt;line-height:100%;text-align:justify;text-justify:inter-ideograph;font-family:Calibri;font-size: 12pt">

		</p>
		<p><font size="1"> </font></p><hr size="3" style="color:#999999" width="100%" align="center"></hr><p style="page-break-after:always">&nbsp;</p><div style="width:100%">

		<p style="margin:0pt;text-align:right;line-height:100%;font-family:Calibri;font-size: 11pt">

			&nbsp;

		</p>

</div>
		<p style="margin:0pt;line-height:100%;text-align:justify;text-justify:inter-ideograph;font-family:Calibri;;font-size: 12pt"><font style="display: inline;font-family:Times New Roman;font-weight:bold;color:#000000;font-size:12pt;">About CryoLife, Inc.</font>
		</p>
		<p style="margin:0pt;line-height:100%;text-align:justify;text-justify:inter-ideograph;font-family:Calibri;font-size: 12pt">
			<font style="display: inline;font-family:Times New Roman;font-weight:bold;color:#000000;font-size:12pt;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Calibri;line-height:115%;font-size: 12pt">
			<font style="display: inline;font-family:Times New Roman;color:#000000;font-size:12pt;">Headquartered in suburban Atlanta, Georgia, CryoLife is a leader in the manufacturing, processing, and distribution of implantable living tissues and medical devices used in cardiac </font><font style="display: inline;font-family:Times New Roman;color:#000000;font-size:12pt;">and vascular </font><font style="display: inline;font-family:Times New Roman;color:#000000;font-size:12pt;">surgical procedures.&nbsp;&nbsp;CryoLife markets and sells products in more than 80 countries worldwide.&nbsp;&nbsp;For additional information about CryoLife, visit our website, </font><font style="display: inline;font-family:Times New Roman;color:#0000FF;font-size:12pt;">www.cryolife.com</font><font style="display: inline;font-family:Times New Roman;color:#000000;font-size:12pt;">.</font>
		</p>
		<p style="margin:0pt;text-align:justify;text-justify:inter-ideograph;font-family:Calibri;line-height:115%;font-size: 12pt">
			<font style="display: inline;font-family:Times New Roman;color:#000000;font-size:12pt;">&#xFEFF;</font>
		</p>
		<p style="margin:0pt 0pt 10pt;text-align:justify;text-justify:inter-ideograph;font-family:Calibri;line-height:115%;font-size: 12pt">
			<font style="display: inline;font-family:Times New Roman;font-size:12pt;">&#xFEFF;</font>
		</p>
		<p><font size="1"> </font></p><div style="width:100%">

		<p style="margin:0pt;text-align:right;line-height:100%;font-family:Calibri;font-size: 11pt">

			&nbsp;

		</p>

		<p style="margin:0pt;text-align:right;line-height:100%;font-family:Calibri;font-size: 11pt">

			&nbsp;

		</p>

</div><hr size="3" style="color:#999999" width="100%" align="center"></hr>
	</div></body>
</html>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
